Betty Lea Schild, age 64, passed away on Tuesday morning, January 16, 2024, at Ascension Via Christi St. Francis Hospital in Wichita, Kansas. Betty was born on November 24, 1959,
The Food and Drug Administration has granted an Orphan Drug Designation to SLS009, a CDK9 inhibitor, for the treatment of patients with relapsed/refractory peripheral T-cell lymphomas.
PALM BEACH GARDENS, Fla. — Roxanne Dee Seader took her last breath peacefully on Nov. 22, 2023. Roxanne was born in Rockland and moved to south Florida in 1982. She
Yescarta is the First and Only Treatment in Nearly 30 Years to Demonstrate Superior Overall Survival for Patients with Relapsed/Refractory Large B-cell Lymphoma Versus Standard of Care as.
21.12.2023 - Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Yescarta (axicabtagene ciloleucel) to include the overall survival (OS) primary analysis from the landmark Phase .